Medical Stocks To Watch Today – July 18th

UnitedHealth Group, Eli Lilly and Company, Abbott Laboratories, Elevance Health, and Johnson & Johnson are the five Medical stocks to watch today, according to MarketBeat’s stock screener tool. Medical stocks are shares of publicly traded companies operating in the healthcare and medical sectors—such as pharmaceutical firms, biotechnology developers, medical device manufacturers, diagnostic laboratories and healthcare service providers. Investors buy and sell these equities to gain exposure to advancements in drug research, medical technology and patient care trends, often seeking growth driven by scientific breakthroughs and demographic shifts. These companies had the highest dollar trading volume of any Medical stocks within the last several days.

UnitedHealth Group (UNH)

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.

NYSE UNH traded down $6.89 during trading on Friday, hitting $281.18. The company’s stock had a trading volume of 7,835,922 shares, compared to its average volume of 7,774,169. The company has a debt-to-equity ratio of 0.71, a current ratio of 0.85 and a quick ratio of 0.85. The company has a market cap of $255.07 billion, a PE ratio of 11.78, a P/E/G ratio of 1.42 and a beta of 0.45. The business’s 50 day simple moving average is $306.43 and its 200-day simple moving average is $434.93. UnitedHealth Group has a fifty-two week low of $248.88 and a fifty-two week high of $630.73.

Eli Lilly and Company (LLY)

Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. The company offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; Jardiance, Mounjaro, and Trulicity for type 2 diabetes; and Zepbound for obesity.

NYSE LLY traded up $8.99 during trading on Friday, hitting $770.49. The company’s stock had a trading volume of 2,000,477 shares, compared to its average volume of 3,675,602. The company has a debt-to-equity ratio of 2.18, a current ratio of 1.37 and a quick ratio of 1.06. Eli Lilly and Company has a fifty-two week low of $677.09 and a fifty-two week high of $972.53. The company has a market cap of $730.22 billion, a PE ratio of 62.67, a P/E/G ratio of 1.15 and a beta of 0.40. The business’s 50 day simple moving average is $766.32 and its 200-day simple moving average is $799.83.

Abbott Laboratories (ABT)

Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The company provides generic pharmaceuticals for the treatment of pancreatic exocrine insufficiency, irritable bowel syndrome or biliary spasm, intrahepatic cholestasis or depressive symptoms, gynecological disorder, hormone replacement therapy, dyslipidemia, hypertension, hypothyroidism, Ménière’s disease and vestibular vertigo, pain, fever, inflammation, and migraine, as well as provides anti-infective clarithromycin, influenza vaccine, and products to regulate physiological rhythm of the colon.

Shares of Abbott Laboratories stock traded up $3.80 on Friday, reaching $124.31. 10,560,579 shares of the stock were exchanged, compared to its average volume of 6,240,272. The company has a quick ratio of 1.27, a current ratio of 1.78 and a debt-to-equity ratio of 0.26. Abbott Laboratories has a twelve month low of $99.71 and a twelve month high of $141.23. The firm has a market capitalization of $216.28 billion, a price-to-earnings ratio of 16.12, a PEG ratio of 2.50 and a beta of 0.73. The business has a 50 day moving average price of $133.17 and a two-hundred day moving average price of $129.38.

Elevance Health (ELV)

Elevance Health, Inc., together with its subsidiaries, operates as a health benefits company in the United States. The company operates through four segments: Health Benefits, CarelonRx, Carelon Services, and Corporate & Other. It offers a variety of health plans and services to program members; health products; an array of fee-based administrative managed care services; and specialty and other insurance products and services, such as stop loss, dental, vision, life, disability, and supplemental health insurance benefits.

Shares of Elevance Health stock traded down $25.15 on Friday, reaching $277.30. 3,842,026 shares of the stock were exchanged, compared to its average volume of 1,659,608. The company has a quick ratio of 1.43, a current ratio of 1.43 and a debt-to-equity ratio of 0.66. Elevance Health has a twelve month low of $276.99 and a twelve month high of $567.26. The firm has a market capitalization of $62.65 billion, a price-to-earnings ratio of 10.83, a PEG ratio of 0.88 and a beta of 0.60. The business has a 50 day moving average price of $374.07 and a two-hundred day moving average price of $396.26.

Johnson & Johnson (JNJ)

Johnson & Johnson is a holding company, which engages in the research, development, manufacture, and sale of products in the healthcare field. It operates through the Innovative Medicine and MedTech segments. The Innovative Medicine segment focuses on immunology, infectious diseases, neuroscience, oncology, cardiovascular and metabolism, and pulmonary hypertension.

Shares of Johnson & Johnson stock traded up $1.25 on Friday, reaching $164.23. 4,385,679 shares of the stock were exchanged, compared to its average volume of 8,125,171. The company has a quick ratio of 1.03, a current ratio of 1.26 and a debt-to-equity ratio of 0.49. Johnson & Johnson has a twelve month low of $140.68 and a twelve month high of $169.99. The firm has a market capitalization of $395.14 billion, a price-to-earnings ratio of 17.57, a PEG ratio of 2.21 and a beta of 0.41. The business has a 50 day moving average price of $154.10 and a two-hundred day moving average price of $154.84.